Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

SOP for Cleaning of Non-Product Contact Areas and Floors in Production

Posted on November 25, 2025November 25, 2025 By digi


SOP for Cleaning of Non-Product Contact Areas and Floors in Production

Step-by-Step SOP for Cleaning Non-Product Contact Areas and Floors in Pharmaceutical Production

Maintaining high standards of cleanliness within pharmaceutical production facilities is essential to ensure compliance with Good Manufacturing Practice (GMP) regulations and to uphold product quality and safety. While much focus is placed on cleaning product contact surfaces, non-product contact areas also require systematic and documented cleaning procedures. This article provides a comprehensive step-by-step tutorial on formulating and implementing an effective area cleaning SOP for non-product contact areas and floors in production environments compliant with US, UK, and EU GMP requirements.

1. Introduction and Scope of the Area Cleaning SOP

Before initiating any cleaning activities, it is paramount to clearly define the scope and inclusion criteria for the SOP. Non-product contact areas typically include corridors, stairwells, walls, shelving, ceilings, floor surfaces outside of direct manufacturing lines, and ancillary rooms such as gowning and changing areas. These zones do not come into direct contact with the product but still pose contamination risks if improperly maintained.

The SOP must articulate the purpose of cleaning these areas: to prevent cross-contamination, dust accumulation, and microbial growth that could compromise the production environment. It shall detail the cleaning methods, agents, schedules, and personnel responsibilities to ensure reproducible and auditable compliance.

Regulatory agencies including the FDA, EMA, and MHRA mandate documented cleaning programs to demonstrate operational control of all production spaces. The EU GMP Guide, Volume 4 highlights the importance of routine cleaning and maintenance of production and adjacent areas during manufacturing.

2. Materials, Equipment, and Cleaning Agents Selection

For routine cleaning of non-product contact areas and floors, selecting appropriate materials and detergents is critical. Acceptable cleaning agents must effectively remove dirt, dust, and soil without adversely affecting surfaces or leaving residues that could become sources of contamination. Ideally, detergents should be non-foaming, biodegradable, and compatible with facility materials such as epoxy flooring or stainless steel.

Also Read:  SOP for Management of GMP Training System and LMS

Essential Cleaning Materials:

  • Mops: Use microfiber or mop heads designed to trap particulate matter rather than merely displace it. Color-coded mops reduce cross-contamination risks between different zones.
  • Cleaning Buckets: Prefer segregated buckets for detergent preparation and rinse water to prevent dilution errors.
  • Detergents: Pharmaceutical-grade, neutral or slightly alkaline detergents tailored to surface types. Avoid harsh alkaline or acidic solutions that might degrade floor finish or wall paint.
  • Personal Protective Equipment (PPE): Gloves, masks, and protective clothing to protect staff and prevent inadvertent contamination.

Use of disinfectants in non-product contact area cleaning is generally not standard unless required during contamination events or as part of environmental monitoring risk assessments. Cleaning agents should be sourced from approved vendors with certificates of analysis available for inspection. Maintain Material Safety Data Sheets (MSDS) and conduct periodic efficacy evaluations.

3. Defining Cleaning Frequency, Schedules, and Personnel Responsibilities

One of the most critical aspects of an effective area cleaning SOP is establishing appropriate cleaning frequency and schedules based on risk assessment and operational workflow. Various factors affect the frequency, including facility layout, production volume, classification of adjacent product contact areas, and documented environmental monitoring results.

Typical cleaning frequencies recommended are as follows:

  • Floors of production corridors and non-classified areas: Daily mopping, preferably at the end of each shift or production day.
  • Walls and shelving: Weekly cleaning to prevent dust accumulation.
  • Ceilings and high-level surfaces: Monthly or as needed based on visual inspections.
  • Changing rooms and gowning areas: Daily cleaning, with additional spot cleaning between shifts.

Cleaning schedules must be documented in centralized logs or digital systems which record date, time, cleaning agent lot numbers, cleaning personnel names, and supervisor verification signatures. Adherence to schedules ensures consistency and facilitates GMP audits and regulatory inspections.

Personnel tasked with executing cleaning activities should receive appropriate training covering SOP procedures, correct use of detergents, mopping techniques, and contamination control principles. Clear responsibilities for production, housekeeping, and QA oversight must be outlined to maintain accountability. Housekeeping staff typically conduct daily routine cleaning, while QA staff periodically audits cleaning effectiveness.

Also Read:  How to Write Clear, Inspection-Ready SOPs for GMP Operations

Integration of cleaning activities within shift handover documentation assists coordination and prevents missed tasks. The SOP should include escalation procedures if cleaning activities are delayed or incomplete.

4. Step-by-Step Procedure for Mopping Floors and Cleaning Non-Product Contact Areas

This section constitutes the operational backbone of the SOP, providing detailed instructions for effective cleaning execution. The steps below emphasize safety, cleaning efficacy, and compliance with GMP:

Step 1: Preparation

  • Wear appropriate PPE (gloves, masks, gowns) before entering the cleaning area.
  • Collect all required equipment: color-coded mop, buckets, approved detergent, and cleaning checklists.
  • Prepare detergent solution as per manufacturer instructions, ensuring correct concentration and mixing in a designated clean area.
  • Secure “Wet Floor” safety signs at entry points to prevent slip hazards during cleaning.

Step 2: Dry Cleaning / Debris Removal

  • Remove any visible debris or dust from floors and horizontal surfaces using a clean dry dust mop or vacuum cleaner with HEPA filtration.
  • Dispose of debris appropriately to avoid cross-contamination.

Step 3: Wet Cleaning (Mopping)

  • Dip mop in detergent solution, wring to avoid excessive wetness which can damage floors or cause hazards.
  • Mop floors systematically starting from the farthest corner of the room, working towards the exit to avoid re-contamination.
  • Use a figure-eight or S-motion mop technique to maximize soil removal and reduce streaking.
  • Change detergent solution according to the defined SOP intervals to maintain cleaning efficacy and avoid dirt buildup.

Step 4: Rinsing

  • If detergent residue risk is a concern, perform rinsing mop with clean water after detergent cleaning following the same mopping pattern.
  • Ensure floors are adequately dried before releasing the area for production or personnel movement.

Step 5: Cleaning Walls, Shelves, and Other Non-Contact Surfaces

  • Use lint-free cloths moistened with detergent solution for cleaning walls and shelving.
  • Apply gentle pressure to remove dust and soil while avoiding surface damage.
  • Perform cleaning vertically from bottom to top to prevent drip marks.
  • Change cloths frequently to prevent redistribution of contamination.

Step 6: Disposal and Cleaning of Equipment

  • Empty and rinse buckets, mop handles, and mop heads after use.
  • Launder or replace mop heads regularly as defined by SOP or environmental monitoring results.
  • Store all equipment in designated clean areas to avoid contamination.
  • Dispose of used cleaning materials according to waste management SOPs.
Also Read:  Common Cleaning Deficiencies on Packaging Lines Highlighted in Audits

Step 7: Documentation and Record Keeping

  • Sign cleaning checklists or logbooks verifying completion of tasks with date, time, and personnel signatures.
  • Report any deviations, unacceptable conditions, or equipment malfunctions to QA immediately.

5. Verification, Monitoring, and Continuous Improvement

Verification of cleaning effectiveness and ongoing monitoring are integral components of the cleaning program to ensure continual GMP compliance and facility cleanliness.

Cleaning Verification Techniques Include:

  • Visual Inspection: Routine assessment of cleanliness post-cleaning for soil, residues, and dust.
  • Environmental Monitoring: Periodic microbiological sampling (surface swabs, air sampling) to detect contamination trends.
  • ATP Bioluminescence Testing: Rapid detection of organic residues facilitating immediate feedback.

Audit findings and environmental monitoring data should be reviewed by QA to adjust cleaning frequencies, schedules, or improve detergent formulations and techniques as needed. Training refreshers are scheduled periodically to maintain staff competency.

Furthermore, the FDA guidance on cGMP for human drugs emphasizes the necessity of validating cleaning procedures, including documenting the rationale behind detergent choice and cleaning frequency.

Robust change control processes must be in place to manage any procedural updates or cleaning agent changes following risk assessment principles outlined by ICH Q9 Quality Risk Management.

6. Conclusion and Best Practices

Implementing a detailed and scientifically sound area cleaning SOP for non-product contact areas and floors is vital for pharmaceutical manufacturing environments. Through clear procedural steps including material selection, cleaning techniques like mopping and detergent application, scheduled frequency, and documentation, companies can ensure compliance with FDA, EMA, MHRA, and PIC/S regulatory expectations.

Key best practices to maintain effective cleaning include:

  • Regular review and updating of cleaning schedules in response to environmental monitoring.
  • Training and qualification of cleaning staff to maintain proficiency and accountability.
  • Use of validated detergents consistent with surface material compatibility.
  • Meticulous documentation with traceability for inspection purposes.
  • Integration of cleaning activities within production planning to minimize disruption and cross-contamination risks.

Adhering to these principles safeguards product quality, protects patient safety, and ensures facility readiness for regulatory inspections.

For additional guidance on cleaning requirements and GMP compliance, consult the comprehensive PIC/S PE 009 guideline on cleaning and disinfection.

Non-Product Contact Areas Tags:areas, cleaning, floors, pharmasop, production, sop

Post navigation

Previous Post: SOP for Product Changeover and Line Cleaning Between Batches
Next Post: SOP for Calibration of Production Equipment and Critical Instruments

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme